Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


A new study has found missing out on sleep may worsen the memory of people with clinically isolated syndrome or relapsing remitting multiple sclerosis (MS). Researchers also found a link between...
A new less expensive, more convenient treatment for multiple sclerosis (MS) could be on the horizon. Ublituximad, made by TG Therapeutics, has been shown to significantly reduce the annualised...
People with multiple sclerosis (MS) often experience symptoms of the condition years before diagnosis, a new study has found. It’s already documented that people with MS often need medical attention...
A diet designed to improve the health of the brain may benefit people with multiple sclerosis (MS), a new study has found. Researchers from the Ichahn School of Medicine at Mount Sinai in New York...
Scientists have discovered the enzyme needed to activate the repair of myelin in the body in a mouse-model study. Called TET1, the enzyme starts to get lost with age, but it is essential in...
Home-based rehabilitation can be helpful for easing fatigue, improving motor and cognitive function, and life quality for people with multiple sclerosis (MS), a new clinical trial has found. The...
MS-UK are celebrating after scooping Campaign of the Year at the Institute of Fundraising East Anglia regional awards for their My MS Marathon campaign.  More than 20 charities across the region...
A new study from Canada has found that women with multiple sclerosis (MS) and breast cancer do not have a higher risk of dying than those without the neurological condition. They did find, though,...
The National Institute for Health and Care Excellence (NICE) has announced it does not recommend Zeposia (ozanimod) for multiple sclerosis (MS) treatment on the NHS in England and Wales. The drug was...
Therapies for people with multiple sclerosis (MS) that deplete B-cells affect antibodies for Covid-19, a new study has found. Most disease-modifying therapies (DMTs) for MS limit immune responses to...

Pages